People are leaving mktg, patient support and mkt access, and we can't find anyone who wants to join.
-
Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page
The turnover here.........................the truth
- Thread starter anonymous
- Start date
-
- Tags
- None
Doesn’t anyone ask WHY?? Is there a plan? Are there patterns gathered from the exit interviews? Doesn’t Japan want to know why so much cost is incurred on recruitment, rehire, retraining?
No plan, never ending meetings that talk about plans, meetings about meetings and plans, more plans to develop plans, no decisions, no action, micromanagement, and unqualified leaders. Other than that, this place is great.
HR is putting together a plan to have meetings to too many meetings
I’m going to approach the week ahead with a new view. Instead of dreading The redundant meetings, false urgency, and self important leadership - I’ll be an active, enthusiastic participant and stir the pot. Then, after the call, go back to Netflix and await the next fire drill.
Today was exhausting. Meetings and calls discussing the same things with different audiences using different slides. Tonight we'll make more changes based on the loudest voice or the last person to comment and start all over again tomorrow. We still won't move anything forward or make any decisions. I guess this is job security for everyone
Had a recruiter outreach about an opportunity in the Patient Service group. Anyone have insights?
The recruiter said there are a few opportunities and my background fit a few of them so I looked on the site. She said it’s due to expansion?
Honestly have not heard one good thing about the company other than “Glad to be outta there!” Same thing I said when I left Pfizer.
Yea this company is being run by people who pretend to know what they are doing. Avoid the pain of looking for a new job right before your LTI kicks in. They will do everything they can to not pay it.
Seriously underperforming with the one rare disease product we have and hoping to add another.
Lots of blame and finger pointing.
Nobody owns anything but everybody is involved with everything.
Scheduling is impossible because everyone needs to be in every meeting.
Meetings never start on time and we never get anything done.
A lot of action items that never get done, so we have more meetings to address those.
We all do a lot but get nothing done.
It's the Japanese way
Not to mention JCity is impossible to get to. And rumor has it 3-4 days a week next year..
Come join us!
Lots of blame and finger pointing.
Nobody owns anything but everybody is involved with everything.
Scheduling is impossible because everyone needs to be in every meeting.
Meetings never start on time and we never get anything done.
A lot of action items that never get done, so we have more meetings to address those.
We all do a lot but get nothing done.
It's the Japanese way
Not to mention JCity is impossible to get to. And rumor has it 3-4 days a week next year..
Come join us!
I use this site as one source. Not always the most credible, But it is still a source. Asked around and did some more digging and took my name out of the mix. Sounds like there's been lots of turnover and the risk far outweighs the rewards.
70% consistent, unremitting turnover is indeed a lot of.. …sour grapes…?
Can’t be leaderships fault. They have all the answers. And if they don’t, we’ll have a meeting and they’ll ask a lot of questions